6 Recruiting Glioblastoma (GBM) Phase 2 Clinical Trials
Active phase 2 studies for glioblastoma (gbm) enrolling across the USA. Verify eligibility and contact site coordinators.
All Glioblastoma (GBM) studiesPhase 2 Studies for Glioblastoma (GBM)
🟡 Not Yet Recruiting Phase1 / Phase2
Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy
📍 Miami Herbert Wertheim Cancer Institute — Miami, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase2
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
📍 University of Alabama at Birmingham O'Neal Comprehensive Cancer Center — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma
📍 Ohio State University Hospital — Columbus, Ohio
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients
📍 Mayo Clinic Hospital — Phoenix, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase2
Enhanced Local Intensified Radiation Therapy in Elderly Glioblastoma: A Phase 2 Hybrid Randomized Trial
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Phase2
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔